Trial of the Week: ATHOS-3 Angiotensin II for the Treatment of Vasodilatory Shock
Special Guest: Dr. Ashish Khanna, MD, MS, FCCP, FCCM, FASA
Dr. Ashish Khanna joins me to highlight the ATHOS-3 trial, where Dr. Khanna is the principal investigator and first author of the NEJM publication.
We discuss the history of angiogensin II, research prior to ATHOS-3, highlight findings from the ATHOS-3 trial, writing for NEJM, experience leading a large prospective RCT in the critically ill, what research do we have since this landmark publication, and much more.
Reference list: https://pharmacytodose.files.wordpress.com/2023/09/athos3-references.pdf
PharmacyToDose.Com
@PharmacyToDose
Learn more about your ad choices. Visit megaphone.fm/adchoices